1. A PHASE 1 STUDY OF THE ANTI‐CD37 ANTIBODY‐DRUG CONJUGATE AGS67E IN ADVANCED LYMPHOID MALIGNANCIES. INTERIM RESULTS. (June 2017) Authors: Sawas, A.; Savage, K.J.; Perez, R.P.; Advani, R.H.; Zaine, J.M.; Lackey, J.M.; Trave, F.; Anand, B.; Chu, R.; Reyno, L.M.; O'Connor, O.A. Journal: Hematological oncology Issue: Volume 35(2017)Supplement 2 Page Start: 49 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Analysis of preclinical and clinical samples after treatment with a CD37 targeting antibody drug conjugate (AGS67E) support a high level of CD37 expression in NHL. (June 2017) Authors: Doñate, F.; Yang, P.; Morrison, K.; Karki, S.; Aviña, H.; Lackey, J.M.; Sawas, A.; Savage, K.J.; Perez, R.P.; Advani, R.H.; Zain, J.M.; O'Connor, O.A.; Reyno, L.M. Journal: Hematological oncology Issue: Volume 35(2017)Supplement 2 Page Start: 290 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. INTEGRATIVE GENOMIC ANALYSIS IDENTIFIES KEY PATHOGENIC CONCEPTS IN PRIMARY MEDIASTINAL LARGE B‐CELL LYMPHOMA. (12th June 2019) Authors: Mottok, A.; Hung, S.S.; Chavez, E.A.; Woolcock, B.; Telenius, A.; Chong, L.C.; Meissner, B.; Nakamura, H.; Gascoyne, R.D.; Connors, J.M.; Ben Neriah, S.; Mungall, A.J.; Marra, M.A.; Siebert, R.; Scott, D.W.; Savage, K.J.; Steidl, C. Journal: Hematological oncology Issue: Volume 37(2019)Supplement 2 Page Start: 156 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. NIVOLUMAB FOR RELAPSED/REFRACTORY CLASSICAL HODGKIN LYMPHOMA AFTER AUTOLOGOUS TRANSPLANT: FULL RESULTS AFTER EXTENDED FOLLOW‐UP OF THE PHASE 2 CHECKMATE 205 TRIAL. (June 2017) Authors: Fanale, M.; Engert, A.; Younes, A.; Armand, P.; Ansell, S.; Zinzani, P.L.; Timmerman, J.M.; Collins, G.P.; Ramchandren, R.; Cohen, J.B.; De Boer, J.P.; Kuruvilla, J.; Savage, K.J.; Trneny, M.; Rodig, S.; Shipp, M.; Kato, K.; Sumbul, A.; Farsaci, B.; Santoro, A. Journal: Hematological oncology Issue: Volume 35(2017)Supplement 2 Page Start: 135 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. OUTCOME OF PATIENTS WITH RELAPSED AND REFRACTORY PERIPHERAL T CELL LYMPHOMA INTENDED FOR STEM CELL TRANSPLANT. (June 2017) Authors: Parkin, S.; Wong, S.; Connors, J.M.; Sehn, L.; Villa, D.; Gerrie, A.; Broady, R.; Power, M.; Toze, C.; Song, K.; Savage, K.J. Journal: Hematological oncology Issue: Volume 35(2017)Supplement 2 Page Start: 241 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. OUTCOME OF PRIMARY MEDIASTINAL LARGE B‐CELL LYMPHOMA IN THE RITUXIMAB ERA: IMPACT OF A PET‐GUIDED APPROACH. (12th June 2019) Authors: Hayden, A.; Tonseth, P.; Villa, D.; Gerrie, A.S.; Scott, D.W.; Freeman, C.L.; Slack, G.W.; Parsons, C.; Pickles, T.; Wilson, D.; Connors, J.M.; Sehn, L.H.; Savage, K.J. Journal: Hematological oncology Issue: Volume 37(2019)Supplement 2 Page Start: 156 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. PROGNOSTIC FACTORS AND IMPACT OF ETOPOSIDE IN ADULTS WITH SYSTEMIC ALK‐POSITIVE ANAPLASTIC LARGE‐CELL LYMPHOMA: A POOLED ANALYSIS OF SIX STUDIES. (June 2017) Authors: Sibon, D.; Nguyen, D.; Schmitz, N.; Suzuki, R.; Feldman, A.L.; Gressin, R.; Lamant, L.; Weisenburger, D.; Nakamura, S.; Ziepert, M.; Maurer, M.J.; Bast, M.; Armitage, J.O.; Vose, J.M.; Tilly, H.; Jais, J.P.; Savage, K.J. Journal: Hematological oncology Issue: Volume 35(2017)Supplement 2 Page Start: 240 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. PROGNOSTIC FACTORS IN PATIENTS WITH RELAPSED OR REFRACTORY SYSTEMIC ANAPLASTIC LARGE T‐CELL LYMPHOMA (ALCL) RECEIVING BRENTUXIMAB VEDOTIN AND OUTCOME AFTER TREATMENT FAILURE. (June 2017) Authors: Oki, Y.; Feldman, T.; Chihara, D.; Sanchez, L.; Fanale, M.; Connors, J.M.; Wong, S.; Savage, K.J. Journal: Hematological oncology Issue: Volume 35(2017)Supplement 2 Page Start: 249 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗